Studies on neuronal apoptoisis in primary forebrain cultures: Neuroprotective/anti-apoptotic action of NR2B NMDA antagonists
- 86 Downloads
While the role of apoptosis in neuronal injury is continually being re-defined, approaches to intervene in the progression of apoptotic injury have been documented to provide neuroprotection against a variety of insults. The present studies were undertaken to systematically study the effects of certain neuroprotective agents against neuronal apoptosis mediated by staurosporine (ST). ST (0.01–5 μM) produced a dose-related apoptotic injury (as characterized by cellular morphology, ‘Comet’ assay analysis [single cell gel electrophoresis] and caspase-3 activation) in primary cultures of forebrain neurons. ST significantly increased caspase-3 activity. The NMDA receptor subtype non-selective antagonist dizocilpine [(+) MK-801; 0.1–50 μM) and a novel sodium channel blocker RS100642 (1.0–250 μM) had no significant effects against ST-induced neurotoxicity. Conversely, NR2B-selective NMDA receptor antagonists CGX-1007 (0.01–50 μM) and ifenprodil (0.01–50 μM) provided dose-dependent neuroprotection against ST-induced neurotoxicity (as measured by neuronal viability and comet assay analysis). CGX-1007 had no significant effect on ST-induced caspase-3 activity; however, ifenprodil did block activation of caspase-3. These studies demonstrate that NR2B NMDA receptor antagonists are anti-apoptotic and may mediate their action via mechanism(s) that are dependent or independent of caspase-3 activation.
KeywordsPrimary neuronal cultures Apoptosis Staurosporine Ifenprodil CGX-1007 Conantokin-G
Unable to display preview. Download preview PDF.
- Bresink I, TA Bentke, VJ Collett, AJ Seal, CG Parsons, JM Henley and GI Collingridge (1996) Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.Brit. J. Pharmacol.,119, 195–204.Google Scholar
- Cohen GM, XM Sun, RT Snowden, D Dinsdale and DN Skilleter (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation.J. Biochem. 286, 331–334.Google Scholar
- Dave JR, Y Lin, M Koenig, HS Ved, L Clapp, JC Hunter and FC Tortella (2001) RS-100642-198, a novel sodium channel blocker, provides differential neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity in primary cultures of rat cerebellar neurons.Neurotoxicity Res. 3, 381–395.Google Scholar
- DeCoster MA, ML Koenig, JC Hunter and FC Tortella (1992) Calcium dynamics in neurons treated with toxic and non-toxic concentrations of glutamate.Neuro Report 9, 773–776.Google Scholar
- Heshmukh M, C Du, X Wang and EM Johson (2002) Exogenous Smac induces competence and permits caspase activation in sympathetic neurons.J. Neurosci. 22, 8018–8027.Google Scholar
- Fischer G, V Mutel, G Trube, P Malherbe, JNC Kew, E Mohacsi MP Heitz and JA Kemp (1997) Ro-25-6981, a highly potent and selective blocker ofN-methyl-D-aspartate receptors containing the NR2B subunit. Characterizationin vitro.J. Pharm. Exp. Ther. 283, 1285–1292.Google Scholar
- Hara H, RM Griedlander, V Gagliardini, C Ayata, K Fink, Z Huang, M Shimizu-Sasamata, J Yuan and MA Moskowitz (1997) Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.Proc. Natl. Acad. Sci. USA 94, 2007–2012.PubMedCrossRefGoogle Scholar
- Williams AJ, JR Dave, J Phillips, Y Lin, R McCabe and FC Tortella (2000) Neuroprotective efficacy and therapeutic window of the high-affinityN-methyl-D-aspartate antagonist conantokin-G:in vitro (primary cerebellar neurons) andin vivo (rat model of transient focal brain ischemia) studies.J. Phamacol. Exp. Ther. 294, 378–386.Google Scholar